Zhejiang Chengbei Pharmaceutical

Zhejiang Chengbei Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the research, development, and manufacturing of high-quality Active Pharmaceutical Ingredients (APIs) and finished drug products. Established in 1993 and headquartered in Linhai, Zhejiang Province, the company has become a globally significant supplier of anti-infectives, including sulfamethoxazole and trimethoprim. Its diverse product portfolio also covers metabolic diseases, with a strong presence in the production of oral hypoglycemic agents such as metformin, gliclazide, and glipizide. With multiple GMP-certified facilities and a focus on international regulatory compliance, Chengbei Pharmaceutical exports its products to over 50 countries and regions worldwide, serving as a critical link in the global pharmaceutical supply chain.